To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene DYNLRB1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
354 supporting clones for gene DYNLRB1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BE503526 carcinoid, lung .a 1 to 426 426 to 1   tiling clone,   426/426
(100 %)
6 diff
(98.6 %id)
BE792510 lung, small cell carcinoma .a 384 to 1263 1 to 879 Q116R N117T D118I L119S T120P ... tiling clone,   879/1165
(75 %)
25 diff
(97.9 %id)
AW972118   .a 412 to 759 1 to 349       349/349
(100 %)
16 diff
(95.5 %id)
H23659 brain .a 803 to 1122 1 to 326   tiling clone, fully sequenced,   326/326
(100 %)
2 diff
(99.4 %id)
AA838721 parathyroid gland, parathyroid tumor .a 1047 to 1425 387 to 9       379/396
(95 %)
0 diff
(100 %id)
BF056422 pooled .a 1047 to 1425 379 to 1       379/419
(90 %)
4 diff
(99.1 %id)
H30738 eye, retina .a 1048 to 1423 384 to 3       382/417
(91 %)
0 diff
(100 %id)
AA908242 carcinoid, lung .a 1056 to 1424 372 to 4       369/372
(99 %)
0 diff
(100 %id)
AA708209 pineal gland .a 1080 to 1426 347 to 1   tiling clone,   347/347
(100 %)
0 diff
(100 %id)
AI077737 senescent fibroblast .a 1080 to 1425 365 to 20   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 346/346
(100 %)
0 diff
(100 %id)
CA414377 Chondrosarcoma Grade II, Left Pelvis .a 1089 to 1425 355 to 19   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 337/337
(100 %)
0 diff
(100 %id)
H23614 brain .a 1092 to 1426 339 to 1   fully sequenced,   339/339
(100 %)
2 diff
(99.5 %id)
AA719579 pineal gland .a 1105 to 1425 321 to 1       321/321
(100 %)
0 diff
(100 %id)
AI129726 uterus .a 1109 to 1426 330 to 13   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 318/318
(100 %)
0 diff
(100 %id)
BE895913 melanotic melanoma, skin .a 1113 to 1419 1 to 307       307/307
(100 %)
0 diff
(100 %id)
BQ359546 head_normal .a 1132 to 1394 295 to 32       264/298
(88 %)
0 diff
(100 %id)
R36713 placenta .a 1133 to 1424 298 to 1       298/368
(80 %)
9 diff
(97.6 %id)
EL951663 eyeball .a 1139 to 1427 1 to 290   tiling clone,   290/296
(97 %)
4 diff
(98.7 %id)
AI284404 Kidney .a 1139 to 1426 288 to 1       288/288
(100 %)
0 diff
(100 %id)
BI092027 cervix .a 1141 to 1426 1 to 286   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 286/286
(100 %)
0 diff
(100 %id)
N45146 liver and spleen .a 1145 to 1377 233 to 1     Submitted on the opposite strand 233/233
(100 %)
0 diff
(100 %id)
DR980553 placenta .a 1176 to 1424 1 to 249   AAA Submitted on the opposite strand 249/249
(100 %)
2 diff
(99.2 %id)
T24814   .a 1206 to 1424 220 to 4       217/220
(98 %)
0 diff
(100 %id)
AF202356   .a 1237 to 1426 189 to 1       189/193
(97 %)
1 diff
(99.5 %id)
BG059838 brain, glioblastoma without EGFR amplification .a 1274 to 1425 152 to 1       152/152
(100 %)
0 diff
(100 %id)
BG222281 brain, glioblastoma with probably TP53 mutation andwithout EGFR amplification .a 1274 to 1427 154 to 1       154/154
(100 %)
0 diff
(100 %id)
AA719601 pineal gland .a 1301 to 1426 126 to 1       126/126
(100 %)
0 diff
(100 %id)
FN053592 breast carcinoma .a 1304 to 1407 1 to 104       104/104
(100 %)
0 diff
(100 %id)
DB478229 hippocampus .b 1 to 497 1 to 497 exact tiling clone,   497/497
(100 %)
0 diff
(100 %id)
DC392262 stomach .c 1 to 555 1 to 555   tiling clone,   555/555
(100 %)
0 diff
(100 %id)
DC325144 brain .c 3 to 590 1 to 589       589/589
(100 %)
1 diff
(99.9 %id)
CN306918 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 16 to 703 1 to 688 K84R     688/688
(100 %)
1 diff
(99.9 %id)
DC330428 hippocampus .c 22 to 603 1 to 582 Q104R     582/582
(100 %)
1 diff
(99.9 %id)
DC321959 brain .c 25 to 584 1 to 560       560/560
(100 %)
0 diff
(100 %id)
DC384128 Prostate .c 25 to 605 1 to 581       581/581
(100 %)
0 diff
(100 %id)
DC391855 Spleen .c 25 to 582 1 to 558       558/558
(100 %)
0 diff
(100 %id)
DC421033 uterus .c 25 to 612 1 to 588       588/588
(100 %)
2 diff
(99.7 %id)
AK294214 amygdala .c 29 to 1100 1 to 1072   tiling clone,   1072/1072
(100 %)
2 diff
(99.9 %id)
DC313668 amygdala .c 29 to 605 1 to 577       577/577
(100 %)
0 diff
(100 %id)
BP212758 cerebrum .c 33 to 439 1 to 412 S112L R113Q G114R S115I K116P ...     412/583
(70 %)
6 diff
(99.0 %id)
T05418   .c 403 to 584 189 to 8       182/290
(62 %)
0 diff
(100 %id)
CB149456 Liver .d 1 to 675 1 to 675 exact tiling clone,   675/675
(100 %)
0 diff
(100 %id)
BM852181 stomach .d 19 to 409 1 to 391       391/391
(100 %)
0 diff
(100 %id)
DA413186 thalamus .d 585 to 1127 2 to 544   tiling clone, capped   543/543
(100 %)
1 diff
(99.9 %id)
BM561321 duodenal adenocarcinoma, cell line, small intestine .e 1 to 985 1 to 981 P101X tiling clone,   981/981
(100 %)
19 diff
(98.1 %id)
BP272876   .e 6 to 1045 1 to 570       548/570
(96 %)
13 diff
(97.8 %id)
BG709221 brain, hypothalamus .f 1 to 687 1 to 686       686/710
(96 %)
7 diff
(99.1 %id)
TI_154035153   .f 4 to 691 36 to 721     Submitted on the opposite strand 686/1022
(67 %)
16 diff
(98.5 %id)
BG714601 brain, hypothalamus .f 5 to 691 1 to 687   tiling clone, AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 687/687
(100 %)
4 diff
(99.5 %id)
CB529514 Aveolar Macrophage, lung .f 6 to 691 705 to 19 N36K T38H T39H T40H Q41P ... AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 687/697
(98 %)
4 diff
(99.5 %id)
BU940760 mixed (pool of 40 RNAs) .f 7 to 683 1 to 682 E6V T7D L8T K9E R10A ... AAA   682/754
(90 %)
9 diff
(98.9 %id)
BU942695 mixed (pool of 40 RNAs) .f 7 to 640 1 to 637   AAA   637/707
(90 %)
7 diff
(99.1 %id)
BG110161 Bone, osteosarcoma, cell line .f 9 to 640 1 to 631   AAA   631/693
(91 %)
2 diff
(99.8 %id)
NM_014183.2   .f 9 to 692 1 to 684   RefSeq, AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 684/684
(100 %)
0 diff
(100 %id)
CB118917 Liver .f 10 to 427 1 to 418       418/418
(100 %)
0 diff
(100 %id)
BG771312 adenocarcinoma, Prostate .f 11 to 690 1 to 678 I50F AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 678/679
(99 %)
5 diff
(99.3 %id)
BM807364 brain, hippocampus .f 11 to 692 12 to 691       680/716
(94 %)
6 diff
(99.2 %id)
FN103855 breast carcinoma .f 13 to 70 58 to 1     Submitted on the opposite strand 58/58
(100 %)
0 diff
(100 %id)
AF132750   .f 15 to 692 1 to 684   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 684/684
(100 %)
14 diff
(98.0 %id)
BU952272 Pancreas, Purified pancreatic islet .f 15 to 346 1 to 333   fully sequenced,   333/333
(100 %)
6 diff
(98.2 %id)
CN299255 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 17 to 692 1 to 676   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 676/676
(100 %)
4 diff
(99.5 %id)
BU932718 mixed (pool of 40 RNAs) .f 17 to 691 1 to 676       676/683
(98 %)
5 diff
(99.3 %id)
BQ771669 Chondrosarcoma Grade II, Left Pelvis .f 17 to 691 693 to 19 I20X AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 675/678
(99 %)
2 diff
(99.8 %id)
CK003097 brain/CNS, Human Brain - Cerebellar Cortex .f 21 to 656 1 to 636       636/636
(100 %)
3 diff
(99.6 %id)
BC002481 Kidney, renal cell adenocarcinoma .f 22 to 692 7 to 675   available from MGC, AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 669/669
(100 %)
1 diff
(99.9 %id)
BM558389 amelanotic melanoma, cell line, skin .f 22 to 692 1 to 671   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 671/672
(99 %)
2 diff
(99.8 %id)
AF161511 blood .f 23 to 691 1 to 669   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 669/669
(100 %)
0 diff
(100 %id)
CR626029 Placenta Cot 25-normalized .f 23 to 691 1 to 669       669/669
(100 %)
0 diff
(100 %id)
BX335331 Placenta Cot 25-normalized .f 23 to 691 1 to 669   fully sequenced,   669/669
(100 %)
0 diff
(100 %id)
AA293684 ovarian tumor, ovary .f 23 to 297 1 to 275   fully sequenced,   275/275
(100 %)
0 diff
(100 %id)
AA456178 ovarian tumor, ovary .f 23 to 431 1 to 409 R58D fully sequenced,   409/409
(100 %)
3 diff
(99.3 %id)
BG282750 adenocarcinoma, cell line, Prostate .f 23 to 689 1 to 665   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 665/667
(99 %)
3 diff
(99.6 %id)
BQ417466 Pancreas, Purified pancreatic islet .f 23 to 346 11 to 334   fully sequenced,   324/334
(97 %)
6 diff
(98.3 %id)
BQ213041 melanotic melanoma, skin .f 23 to 691 12 to 680 E77* AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 669/680
(98 %)
7 diff
(99.0 %id)
BU171468 melanotic melanoma, skin .f 23 to 691 12 to 679   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 668/679
(98 %)
7 diff
(99.0 %id)
CB147656 Liver .f 23 to 624 1 to 602       602/602
(100 %)
0 diff
(100 %id)
BQ576012 Chondrosarcoma Grade II, Left Pelvis .f 23 to 691 685 to 19 I20X AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 667/676
(98 %)
3 diff
(99.6 %id)
BG288854 bladder, transitional cell papilloma, cell line .f 24 to 693 1 to 678   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 678/678
(100 %)
9 diff
(98.7 %id)
BG829134 muscle, rhabdomyosarcoma .f 25 to 691 1 to 667       667/685
(97 %)
4 diff
(99.5 %id)
BE440145 Trabecular meshwork .f 26 to 691 1 to 663   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 663/663
(100 %)
5 diff
(99.3 %id)
BG024629 lymph, lymphoma, cell line .f 26 to 692 1 to 671       671/817
(82 %)
7 diff
(99.2 %id)
BI547499 brain, hippocampus .f 27 to 666 1 to 640 G19A     640/668
(95 %)
7 diff
(99.0 %id)
CD175238 embryonic stem cells, WA01, passage 38 .f 29 to 691 22 to 684 M46V AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 663/684
(96 %)
8 diff
(98.9 %id)
D60290   .f 29 to 423 1 to 396 E3X D59X I60H D61R Q63P ... fully sequenced,   396/396
(100 %)
2 diff
(99.5 %id)
BQ917395 sciatic nerve .f 31 to 691 1 to 661       661/666
(99 %)
1 diff
(99.9 %id)
BP204178 coronary artery .f 32 to 612 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BP226445   .f 32 to 612 1 to 581       581/581
(100 %)
0 diff
(100 %id)
DB481983 hippocampus .f 32 to 511 1 to 480       480/480
(100 %)
2 diff
(99.6 %id)
DB483794 hippocampus .f 32 to 478 1 to 447       447/447
(100 %)
0 diff
(100 %id)
TI_44168288   .f 32 to 666 88 to 722 G19A     635/750
(84 %)
9 diff
(98.8 %id)
CB110920 Liver .f 32 to 597 1 to 566       566/566
(100 %)
0 diff
(100 %id)
DA734845   .f 32 to 693 2 to 666 V57M fully sequenced, capped   665/665
(100 %)
7 diff
(99.0 %id)
BP324603 Pancreas .f 32 to 615 1 to 584       584/584
(100 %)
0 diff
(100 %id)
BQ639931 eye, retina .f 34 to 660 6 to 632       627/632
(99 %)
6 diff
(99.1 %id)
CB106879 Liver .f 34 to 496 1 to 463       463/463
(100 %)
0 diff
(100 %id)
CB126229 Liver .f 34 to 651 1 to 618       618/618
(100 %)
0 diff
(100 %id)
BU532569 mixed (pool of 40 RNAs) .f 35 to 687 1 to 655 D65E     655/840
(77 %)
9 diff
(99.0 %id)
CR979443 T-Lymphocytes .f 36 to 688 1 to 653       653/653
(100 %)
0 diff
(100 %id)
BF338864 brain, glioblastoma with EGFR amplification .f 37 to 692 1 to 656   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 656/656
(100 %)
5 diff
(99.3 %id)
BU602061 mixed (pool of 40 RNAs) .f 37 to 690 1 to 654       654/835
(78 %)
4 diff
(99.6 %id)
CB122253 Liver .f 37 to 635 1 to 599       599/599
(100 %)
0 diff
(100 %id)
BX646255   .f 39 to 673 1 to 635   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 635/635
(100 %)
2 diff
(99.7 %id)
TI_154126396   .f 39 to 691 737 to 85   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 653/946
(69 %)
3 diff
(99.7 %id)
CA416542 Chondrosarcoma Cell line .f 39 to 691 671 to 19   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 653/657
(99 %)
3 diff
(99.6 %id)
EL950626 eyeball .f 40 to 216 1 to 177       177/177
(100 %)
3 diff
(98.4 %id)
CD674040 eye, lens .f 40 to 178 1 to 139   fully sequenced, Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 139/139
(100 %)
0 diff
(100 %id)
AF165516   .f 41 to 692 1 to 652   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 652/652
(100 %)
5 diff
(99.3 %id)
T95369 liver and spleen .f 41 to 327 1 to 289   fully sequenced,   289/289
(100 %)
10 diff
(96.6 %id)
BM913885 astrocytoma grade IV, cell line, brain .f 41 to 689 1 to 649       649/1134
(57 %)
7 diff
(99.4 %id)
BM997999 lung, Metastatic Chondrosarcoma .f 42 to 691 668 to 19   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 650/650
(100 %)
0 diff
(100 %id)
BP212838 cerebrum .f 43 to 617 1 to 575       575/575
(100 %)
0 diff
(100 %id)
BP346785 brain .f 43 to 629 1 to 587       587/587
(100 %)
0 diff
(100 %id)
BP357057 mammary gland .f 43 to 630 1 to 588       588/588
(100 %)
0 diff
(100 %id)
BQ446083 Knee, Osteoarthritic Cartilage .f 43 to 691 667 to 19 I20X AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 649/649
(100 %)
0 diff
(100 %id)
CD672469 eye, Iris .f 44 to 346 1 to 303   fully sequenced, Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 303/303
(100 %)
2 diff
(99.4 %id)
CD675573 eye, lens .f 44 to 679 16 to 651       636/651
(97 %)
6 diff
(99.1 %id)
R50440 breast .f 44 to 346 1 to 310   fully sequenced,   310/310
(100 %)
3 diff
(99.1 %id)
H39521 breast .f 44 to 258 1 to 215   fully sequenced,   215/215
(100 %)
1 diff
(99.6 %id)
AW327451 blood, T cell leukemia .f 44 to 346 1 to 303   fully sequenced, Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 303/303
(100 %)
4 diff
(98.7 %id)
BE273977 Kidney, renal cell adenocarcinoma .f 44 to 693 1 to 648 Q12H S13E Q14P K15E V17S ...     648/656
(98 %)
6 diff
(99.1 %id)
BI752603 brain .f 44 to 692 1 to 649   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 649/649
(100 %)
2 diff
(99.7 %id)
BM800564 leiomyosarcoma, uterus .f 44 to 690 12 to 658   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 647/658
(98 %)
6 diff
(99.1 %id)
BM510285 insulinoma, Pancreas .f 44 to 346 8 to 310   fully sequenced,   303/310
(97 %)
6 diff
(98.1 %id)
BQ422558 large cell carcinoma, lung .f 44 to 691 1 to 648   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 648/648
(100 %)
0 diff
(100 %id)
TI_57219646   .f 44 to 692 66 to 714   tiling clone, AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 649/714
(90 %)
8 diff
(98.9 %id)
TI_57231502   .f 44 to 693 30 to 689       660/1045
(63 %)
27 diff
(97.5 %id)
H46320 brain .f 45 to 351 1 to 310   fully sequenced,   310/310
(100 %)
2 diff
(99.4 %id)
AA284908 ovarian tumor, ovary .f 45 to 425 1 to 381 E5G E6G T7D L8T K9E ... fully sequenced,   381/381
(100 %)
4 diff
(99.0 %id)
BG337002 leiomyosarcoma cell line, uterus .f 45 to 691 1 to 647 G19E I20S I21S V22S V23* AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 647/647
(100 %)
2 diff
(99.7 %id)
BI757906 brain .f 45 to 693 1 to 648 V4G E5G E6G T7D L8T ...     648/1073
(60 %)
8 diff
(99.3 %id)
CX754052 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .f 45 to 692 1 to 647   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 647/647
(100 %)
1 diff
(99.9 %id)
CN299238 embryonic stem cells, DMSO-treated H9 cellline .f 46 to 686 1 to 641       641/641
(100 %)
0 diff
(100 %id)
BI756438 brain .f 46 to 693 1 to 648       648/695
(93 %)
3 diff
(99.6 %id)
BU185217 ductal carcinoma, cell line, Pancreas .f 46 to 691 1 to 646   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 646/646
(100 %)
0 diff
(100 %id)
BU168439 ductal carcinoma, cell line, Pancreas .f 46 to 691 1 to 646   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 646/646
(100 %)
0 diff
(100 %id)
BQ879058 ductal carcinoma, cell line, Pancreas .f 46 to 691 1 to 646   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 646/646
(100 %)
0 diff
(100 %id)
TI_57220285   .f 46 to 693 31 to 678       648/778
(83 %)
9 diff
(98.9 %id)
BM690300 eye, human retina .f 46 to 431 36 to 421   fully sequenced, Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 386/421
(91 %)
6 diff
(98.6 %id)
BF820061 kidney_tumor .f 47 to 346 304 to 1     Submitted on the opposite strand 304/305
(99 %)
17 diff
(94.5 %id)
AW405954 lymph .f 47 to 428 8 to 389       382/389
(98 %)
6 diff
(98.5 %id)
TI_154143386   .f 47 to 611 81 to 643       563/563
(100 %)
15 diff
(97.4 %id)
N40719 melanocyte .f 48 to 450 1 to 402 Q12R S13A Q14R K15R G16E ... fully sequenced,   402/402
(100 %)
3 diff
(99.3 %id)
BE792591 lung, small cell carcinoma .f 48 to 692 1 to 644 G19E I20S I21S V22S V23* AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 644/644
(100 %)
1 diff
(99.9 %id)
BQ056781 lymph, lymphoma, cell line .f 48 to 692 1 to 645   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 645/645
(100 %)
0 diff
(100 %id)
TI_159708238   .f 48 to 692 745 to 101   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 645/1015
(63 %)
1 diff
(100.0 %id)
EL947017 eyeball .f 50 to 506 1 to 458       458/458
(100 %)
5 diff
(99.0 %id)
AV759543 bone marrow .f 51 to 693 1 to 643       643/647
(99 %)
1 diff
(99.9 %id)
AW161252 brain, frontal lobe .f 52 to 496 1 to 445       445/445
(100 %)
0 diff
(100 %id)
BI467035 Pancreas, Purified pancreatic islet .f 53 to 601 3 to 551       549/551
(99 %)
6 diff
(99.0 %id)
BI193666 epithelioid carcinoma cell line, Pancreas .f 53 to 691 1 to 639 Q18H     639/922
(69 %)
4 diff
(99.6 %id)
BM903808 eye, retinoblastoma .f 53 to 691 3 to 641   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 639/641
(99 %)
6 diff
(99.1 %id)
BQ630963.
matches multiple genes
insulinoma, Pancreas .f 53 to 524 3 to 474     Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base), also hits gene FAM120A 472/474
(99 %)
6 diff
(98.8 %id)
BG831916 epithelioid carcinoma cell line, Pancreas .f 54 to 692 1 to 639   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 639/639
(100 %)
1 diff
(99.9 %id)
EB385890 eye, optic nerve .f 54 to 692 1 to 639   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 639/639
(100 %)
0 diff
(100 %id)
CR977606 T-Lymphocytes .f 54 to 692 1 to 639   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 639/639
(100 %)
0 diff
(100 %id)
W47069 senescent fibroblast .f 55 to 457 1 to 405 R58V fully sequenced,   405/405
(100 %)
4 diff
(99.1 %id)
BM711463 eye, fetal eyes .f 55 to 178 1 to 124   fully sequenced, Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 124/124
(100 %)
0 diff
(100 %id)
CN342792 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .f 56 to 569 13 to 522 A2N     514/522
(98 %)
9 diff
(98.3 %id)
H45788 breast .f 56 to 327 1 to 273   fully sequenced,   273/273
(100 %)
10 diff
(96.4 %id)
BG030777 breast, mammary adenocarcinoma, cell line .f 56 to 691 1 to 636 G19E I20S I21S V22S V23* AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 636/636
(100 %)
2 diff
(99.7 %id)
BI850489 breast, mammary adenocarcinoma, cell line .f 56 to 677 1 to 622       622/626
(99 %)
6 diff
(99.1 %id)
AK026864 adipose tissue .f 58 to 693 1 to 636   available from FLJ,   636/651
(97 %)
3 diff
(99.6 %id)
BQ637217 eye, retina .f 58 to 649 1 to 592       592/592
(100 %)
0 diff
(100 %id)
BE736614 adenocarcinoma, Pancreas .f 59 to 678 1 to 624       624/637
(97 %)
9 diff
(98.6 %id)
AW939113 denis_drash .f 61 to 341 295 to 10     Submitted on the opposite strand 286/295
(96 %)
6 diff
(98.0 %id)
AW939939 denis_drash .f 61 to 341 295 to 10     Submitted on the opposite strand 286/295
(96 %)
6 diff
(98.0 %id)
H67414 liver and spleen .f 61 to 364 1 to 307 R58V fully sequenced,   307/307
(100 %)
2 diff
(99.4 %id)
AF178431   .f 69 to 359 1 to 291       291/291
(100 %)
0 diff
(100 %id)
AY026513 placenta .f 69 to 359 1 to 291       291/291
(100 %)
0 diff
(100 %id)
AI718386 colon .f 69 to 693 626 to 3 N36T T38P T39P T40X Q41S ...     624/626
(99 %)
1 diff
(99.9 %id)
BM690827 eye, Retina Foveal and Macular .f 70 to 691 1 to 622   fully sequenced, AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 622/622
(100 %)
10 diff
(98.4 %id)
AW605510 denis_drash .f 71 to 335 267 to 3       265/277
(95 %)
1 diff
(99.7 %id)
AW939121 denis_drash .f 71 to 406 343 to 3     Submitted on the opposite strand 339/353
(96 %)
9 diff
(97.5 %id)
AW939170 denis_drash .f 71 to 406 343 to 3     Submitted on the opposite strand 339/353
(96 %)
9 diff
(97.5 %id)
BE707535 head_neck .f 71 to 267 197 to 2       196/206
(95 %)
0 diff
(100 %id)
BF349007 denis_drash .f 71 to 358 315 to 26       290/336
(86 %)
5 diff
(98.6 %id)
BF374960 stomach .f 71 to 247 178 to 1       178/183
(97 %)
3 diff
(98.4 %id)
BF762447 colon_est .f 71 to 183 21 to 131       111/132
(84 %)
7 diff
(94.7 %id)
BG207678   .f 71 to 690 629 to 8     Submitted on the opposite strand 622/859
(72 %)
16 diff
(98.2 %id)
BQ314807 denis_drash .f 71 to 358 315 to 26       290/336
(86 %)
5 diff
(98.6 %id)
CR596463 fetal brain .f 71 to 679 1 to 609       609/609
(100 %)
0 diff
(100 %id)
EC567635 Prostate .f 71 to 155 1 to 83       83/91
(91 %)
6 diff
(93.5 %id)
FN055238 breast carcinoma .f 71 to 161 91 to 1     Submitted on the opposite strand 91/91
(100 %)
0 diff
(100 %id)
D59621   .f 71 to 311 8 to 246   fully sequenced,   239/246
(97 %)
8 diff
(96.8 %id)
D80282 brain .f 71 to 458 8 to 393   fully sequenced,   386/393
(98 %)
7 diff
(98.3 %id)
H29998 eye, retina .f 71 to 400 1 to 335   fully sequenced,   335/335
(100 %)
2 diff
(99.5 %id)
BE314492 brain, neuroblastoma .f 71 to 693 648 to 27     Submitted on the opposite strand 622/742
(83 %)
3 diff
(99.6 %id)
BG577096 breast, mammary adenocarcinoma, cell line .f 71 to 691 7 to 627   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 621/627
(99 %)
6 diff
(99.1 %id)
TI_57221432   .f 71 to 693 93 to 714       622/1139
(54 %)
11 diff
(99.1 %id)
TI_57193537   .f 71 to 690 24 to 642   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 619/619
(100 %)
3 diff
(99.6 %id)
H12866 placenta .f 72 to 327 1 to 256       256/554
(46 %)
8 diff
(98.6 %id)
H78760 liver and spleen .f 72 to 383 1 to 323   fully sequenced,   323/323
(100 %)
5 diff
(98.5 %id)
W03602 melanocyte .f 72 to 468 1 to 391   fully sequenced,   391/391
(100 %)
1 diff
(99.8 %id)
AA410766 ovarian tumor, ovary .f 74 to 506 1 to 432       432/432
(100 %)
2 diff
(99.6 %id)
TI_154047802   .f 74 to 692 703 to 85   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 619/959
(64 %)
0 diff
(100 %id)
BU189058 melanotic melanoma, skin .f 75 to 691 8 to 624   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 617/624
(98 %)
6 diff
(99.1 %id)
BE905565 epithelioid carcinoma, Pancreas .f 76 to 686 1 to 611       611/611
(100 %)
0 diff
(100 %id)
BE884452 leiomyosarcoma, uterus .f 76 to 650 1 to 575       575/575
(100 %)
0 diff
(100 %id)
BE077322 breast .f 77 to 388 314 to 3     Submitted on the opposite strand 312/321
(97 %)
0 diff
(100 %id)
BG181184   .f 77 to 612 1 to 545       545/814
(66 %)
38 diff
(95.4 %id)
TI_57188848   .f 77 to 692 80 to 696   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 617/644
(95 %)
7 diff
(99.0 %id)
BU184671 leiomyosarcoma, uterus .f 79 to 692 1 to 614   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 614/614
(100 %)
0 diff
(100 %id)
CA848530 Pancreas, Purified pancreatic islet .f 79 to 664 1 to 586   fully sequenced,   586/586
(100 %)
0 diff
(100 %id)
CB070393 Pancreas, Purified pancreatic islet .f 79 to 440 1 to 362   fully sequenced,   362/362
(100 %)
0 diff
(100 %id)
TI_57199602   .f 79 to 692 79 to 691   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 613/691
(88 %)
6 diff
(99.2 %id)
D60103   .f 80 to 450 1 to 371   fully sequenced,   371/371
(100 %)
0 diff
(100 %id)
AW796569 uterus .f 81 to 263 1 to 182       182/182
(100 %)
1 diff
(99.5 %id)
BF175027 blood .f 81 to 477 1 to 397       397/397
(100 %)
0 diff
(100 %id)
BF802186 colon_ins .f 81 to 511 450 to 18     Submitted on the opposite strand 433/450
(96 %)
2 diff
(99.6 %id)
BG029888 breast, mammary adenocarcinoma, cell line .f 82 to 692 1 to 611   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 611/611
(100 %)
0 diff
(100 %id)
BF311976 brain, neuroblastoma .f 83 to 693 619 to 10     Submitted on the opposite strand 610/891
(68 %)
2 diff
(99.8 %id)
CN299179 embryonic stem cells, DMSO-treated H9 cellline .f 85 to 393 1 to 309       309/309
(100 %)
0 diff
(100 %id)
EC478513 Prostate .f 87 to 178 1 to 89       89/92
(96 %)
9 diff
(90.3 %id)
AW404470 lymph .f 88 to 531 1 to 444       444/444
(100 %)
4 diff
(99.1 %id)
EC566526 Prostate .f 89 to 182 1 to 93       93/93
(100 %)
1 diff
(99.0 %id)
BU158644 large cell carcinoma, lung .f 89 to 691 1 to 603   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 603/603
(100 %)
0 diff
(100 %id)
BE906011 epithelioid carcinoma, Pancreas .f 92 to 685 1 to 594       594/594
(100 %)
0 diff
(100 %id)
BU619291 Cell Line, Chondrosarcoma .f 94 to 690 615 to 19   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 597/603
(99 %)
0 diff
(100 %id)
TI_154141425   .f 95 to 566 82 to 553       472/472
(100 %)
1 diff
(99.8 %id)
BM708016 eye, RPE and Choroid .f 95 to 178 1 to 84   fully sequenced, Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 84/84
(100 %)
0 diff
(100 %id)
BE936704 ovary .f 98 to 439 416 to 74       343/428
(80 %)
12 diff
(97.2 %id)
FN145955 breast carcinoma .f 99 to 197 96 to 1     Submitted on the opposite strand 96/96
(100 %)
5 diff
(94.8 %id)
R24688 placenta .f 101 to 327 1 to 230       230/272
(84 %)
13 diff
(95.3 %id)
BQ614575 insulinoma, Pancreas .f 101 to 379 286 to 8     Submitted on the opposite strand 279/290
(96 %)
0 diff
(100 %id)
BQ787246 Pancreas, Purified pancreatic islet .f 103 to 178 1 to 76   fully sequenced,   76/76
(100 %)
0 diff
(100 %id)
AI910285 breast .f 105 to 406 307 to 6       302/307
(98 %)
2 diff
(99.4 %id)
FN098639 breast carcinoma .f 106 to 203 98 to 1     Submitted on the opposite strand 98/98
(100 %)
0 diff
(100 %id)
AV735390 cord Blood .f 108 to 610 39 to 528       490/594
(82 %)
26 diff
(95.7 %id)
AV741132 cord Blood .f 108 to 642 39 to 584       546/584
(93 %)
27 diff
(95.4 %id)
AV738810 cord Blood .f 108 to 552 39 to 500       427/502
(85 %)
37 diff
(92.7 %id)
AV745004 cord Blood .f 108 to 612 39 to 544       506/545
(92 %)
31 diff
(94.4 %id)
AI054051 ovary, papillary serous carcinoma .f 108 to 300 199 to 7   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 193/218
(88 %)
0 diff
(100 %id)
CA943316 Pancreas, Purified pancreatic islet .f 108 to 692 1 to 585   fully sequenced, AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 585/585
(100 %)
0 diff
(100 %id)
AA121143   .f 110 to 170 1 to 61       61/61
(100 %)
1 diff
(98.4 %id)
BF054911 brain, oligodendroglioma .f 113 to 524 1 to 412       412/412
(100 %)
0 diff
(100 %id)
TI_154143711   .f 113 to 657 80 to 625       546/547
(99 %)
4 diff
(99.3 %id)
BU731419 eye, RPE and Choroid .f 115 to 692 596 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 578/578
(100 %)
1 diff
(99.9 %id)
BX335330 Placenta Cot 25-normalized .f 117 to 670 563 to 11   fully sequenced,   553/563
(98 %)
0 diff
(100 %id)
CD674039 eye, lens .f 117 to 690 590 to 17   fully sequenced, AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 574/574
(100 %)
0 diff
(100 %id)
BQ786969 Pancreas, Purified pancreatic islet .f 117 to 690 574 to 1   fully sequenced,   574/574
(100 %)
1 diff
(99.9 %id)
AW934822 denis_drash .f 118 to 460 333 to 1     Submitted on the opposite strand 333/333
(100 %)
0 diff
(100 %id)
H04077 placenta .f 121 to 391 1 to 277   fully sequenced,   277/277
(100 %)
2 diff
(99.3 %id)
BE163199 head_neck .f 122 to 370 288 to 41     Submitted on the opposite strand 248/288
(86 %)
0 diff
(100 %id)
CD675456 eye, lens .f 122 to 690 1 to 569   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 569/569
(100 %)
0 diff
(100 %id)
AA074113 pineal gland .f 122 to 297 1 to 178       178/179
(99 %)
8 diff
(95.6 %id)
BQ001615 lung, Metastatic Chondrosarcoma .f 127 to 690 582 to 19   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 564/564
(100 %)
0 diff
(100 %id)
BM670714 eye, fetal eyes .f 127 to 691 583 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 565/565
(100 %)
0 diff
(100 %id)
CD107954 brain, Pituitary .f 134 to 691 1 to 558   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 558/558
(100 %)
0 diff
(100 %id)
BF038436 adenocarcinoma, ovary .f 146 to 683 573 to 30   AAA Submitted on the opposite strand 544/875
(62 %)
16 diff
(98.2 %id)
TI_154191870   .f 146 to 691 66 to 613   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 548/568
(96 %)
6 diff
(99.0 %id)
BF083284 colon .f 161 to 683 554 to 34       521/554
(94 %)
1 diff
(99.9 %id)
TI_154131997   .f 163 to 691 642 to 113   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 530/896
(59 %)
8 diff
(99.2 %id)
TI_154191766   .f 169 to 658 52 to 540       489/985
(49 %)
3 diff
(99.7 %id)
DB550840 hippocampus .f 170 to 690 1 to 521     Submitted on the opposite strand 521/522
(99 %)
2 diff
(99.7 %id)
AA595074 Prostate, prostate tumor .f 171 to 523 353 to 1       353/353
(100 %)
0 diff
(100 %id)
BF744548 breast .f 172 to 404 262 to 30     Submitted on the opposite strand 233/264
(88 %)
2 diff
(99.3 %id)
BF806763 colon_ins .f 176 to 490 315 to 1     Submitted on the opposite strand 315/320
(98 %)
9 diff
(97.2 %id)
BF083315 colon .f 177 to 684 532 to 23       510/534
(95 %)
4 diff
(99.3 %id)
BQ340402 nervous_normal .f 182 to 522 343 to 1       343/343
(100 %)
4 diff
(98.9 %id)
BF806758 colon_ins .f 188 to 485 305 to 7     Submitted on the opposite strand 299/305
(98 %)
1 diff
(99.7 %id)
BF812275 colon_ins .f 188 to 479 298 to 2     Submitted on the opposite strand 297/298
(99 %)
9 diff
(97.0 %id)
BF812317 colon_ins .f 188 to 490 310 to 9     Submitted on the opposite strand 302/310
(97 %)
1 diff
(99.7 %id)
BF812319 colon_ins .f 188 to 490 304 to 4     Submitted on the opposite strand 301/304
(99 %)
1 diff
(99.7 %id)
BF993637 placenta_normal .f 188 to 486 308 to 10       299/308
(97 %)
0 diff
(100 %id)
BQ324316 colon_ins .f 188 to 486 302 to 1       302/302
(100 %)
13 diff
(95.7 %id)
BF809877 colon_ins .f 196 to 640 449 to 3     Submitted on the opposite strand 447/460
(97 %)
4 diff
(99.2 %id)
GD151797   .f 201 to 300 1 to 100       100/101
(99 %)
5 diff
(95.1 %id)
AI277103 adenocarcinoma, colon .f 202 to 691 490 to 1       490/490
(100 %)
0 diff
(100 %id)
AA420794   .f 208 to 523 314 to 1       314/316
(99 %)
3 diff
(99.1 %id)
BE711015 head_neck .f 219 to 358 32 to 171       140/171
(81 %)
6 diff
(96.5 %id)
CD674711 eye, lens .f 221 to 632 1 to 412       412/412
(100 %)
0 diff
(100 %id)
AI131065 heart .f 222 to 683 462 to 1       462/462
(100 %)
0 diff
(100 %id)
BU071120 insulinoma, Pancreas .f 224 to 692 485 to 17   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 469/469
(100 %)
0 diff
(100 %id)
H28036 breast .f 228 to 681 457 to 2   fully sequenced,   456/457
(99 %)
5 diff
(99.0 %id)
AA837361 germinal center B cell .f 231 to 523 292 to 1       292/292
(100 %)
2 diff
(99.4 %id)
CU446110 epidermis .f 241 to 511 1 to 271       271/304
(89 %)
9 diff
(97.1 %id)
DB546876 hippocampus .f 242 to 691 1 to 450     Submitted on the opposite strand 450/450
(100 %)
3 diff
(99.4 %id)
AI053491 ovary, papillary serous carcinoma .f 243 to 523 281 to 1       281/281
(100 %)
0 diff
(100 %id)
AI752468 Bone, Hip .f 247 to 679 441 to 9       433/448
(96 %)
0 diff
(100 %id)
AW751361 colon .f 255 to 381 1 to 127       127/143
(88 %)
7 diff
(95.2 %id)
BY999704   .f 261 to 691 1 to 431     Submitted on the opposite strand 431/438
(98 %)
1 diff
(99.8 %id)
AA398454 ovarian tumor, ovary .f 267 to 691 425 to 1   fully sequenced,   425/425
(100 %)
0 diff
(100 %id)
TI_151739962   .f 267 to 689 570 to 148       423/1351
(31 %)
5 diff
(99.7 %id)
BG943680 blood .f 279 to 692 453 to 40   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 414/414
(100 %)
0 diff
(100 %id)
AA530948 normal prostatic epithelial cells, Prostate .f 279 to 523 244 to 1       244/248
(98 %)
4 diff
(98.4 %id)
D59620   .f 281 to 691 410 to 1   fully sequenced,   410/410
(100 %)
4 diff
(99.1 %id)
H45789 breast .f 282 to 674 396 to 1   fully sequenced,   396/396
(100 %)
2 diff
(99.5 %id)
T95290 liver and spleen .f 285 to 679 395 to 1   fully sequenced,   395/395
(100 %)
0 diff
(100 %id)
BM508110 insulinoma, Pancreas .f 285 to 676 394 to 1   fully sequenced,   394/394
(100 %)
1 diff
(99.8 %id)
BQ288011 Pancreas, Purified pancreatic islet .f 285 to 690 407 to 1   fully sequenced,   407/407
(100 %)
0 diff
(100 %id)
BU952009 Pancreas, Purified pancreatic islet .f 285 to 693 409 to 1   fully sequenced,   409/409
(100 %)
0 diff
(100 %id)
CA943428 Pancreas, Purified pancreatic islet .f 285 to 693 410 to 2   fully sequenced, Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 409/410
(99 %)
0 diff
(100 %id)
BM663708 eye, Retina Foveal and Macular .f 285 to 691 424 to 18   fully sequenced, AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 407/407
(100 %)
0 diff
(100 %id)
CD672468 eye, Iris .f 289 to 691 420 to 18   fully sequenced, AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 403/403
(100 %)
0 diff
(100 %id)
AW327452 blood, T cell leukemia .f 294 to 691 417 to 20   fully sequenced, AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 398/398
(100 %)
0 diff
(100 %id)
R50441 breast .f 295 to 691 397 to 1   fully sequenced,   397/397
(100 %)
1 diff
(99.8 %id)
CN299146 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 300 to 693 407 to 14     Submitted on the opposite strand 394/407
(96 %)
0 diff
(100 %id)
AA846622 parathyroid gland, parathyroid tumor .f 307 to 692 386 to 1       386/386
(100 %)
0 diff
(100 %id)
AA937383 bowel (skin primary), metastatic melanoma to bowel .f 308 to 523 216 to 1       216/216
(100 %)
0 diff
(100 %id)
BG205700   .f 309 to 529 1 to 221       221/221
(100 %)
13 diff
(94.2 %id)
BF365236 nervous_tumor .f 313 to 537 37 to 261       225/261
(86 %)
6 diff
(97.8 %id)
BX393511 Neuroblastoma Cot 10-normalized .f 313 to 691 1 to 379       379/379
(100 %)
0 diff
(100 %id)
FN131914 breast carcinoma .f 315 to 420 1 to 103       103/103
(100 %)
5 diff
(95.2 %id)
H46257 brain .f 321 to 673 353 to 1   fully sequenced,   353/353
(100 %)
0 diff
(100 %id)
AA761828 germinal center B cell .f 322 to 523 202 to 1       202/202
(100 %)
0 diff
(100 %id)
FN113154 breast carcinoma .f 326 to 404 1 to 76       76/93
(81 %)
3 diff
(96.8 %id)
H67365 liver and spleen .f 334 to 668 337 to 1   fully sequenced,   337/337
(100 %)
1 diff
(99.8 %id)
AA169577.
matches multiple genes
  .f 337 to 524 1 to 188     also hits gene CCDC25 188/188
(100 %)
0 diff
(100 %id)
H78677 liver and spleen .f 353 to 668 318 to 1   fully sequenced,   318/318
(100 %)
0 diff
(100 %id)
AA169876.
matches multiple genes
  .f 355 to 523 169 to 1     also hits gene CDC40 169/169
(100 %)
0 diff
(100 %id)
H12867 placenta .f 357 to 664 308 to 1       308/430
(71 %)
0 diff
(100 %id)
H03384 placenta .f 361 to 671 314 to 1   fully sequenced,   314/314
(100 %)
0 diff
(100 %id)
AA826973 epithelium (cell line), Prostate .f 363 to 523 161 to 1       161/161
(100 %)
0 diff
(100 %id)
H29899 eye, retina .f 370 to 691 322 to 1   fully sequenced,   322/322
(100 %)
1 diff
(99.7 %id)
AA284778 ovarian tumor, ovary .f 395 to 691 297 to 1   fully sequenced,   297/297
(100 %)
1 diff
(99.7 %id)
AA443113 ovarian tumor, ovary .f 401 to 692 292 to 1   fully sequenced,   292/292
(100 %)
1 diff
(99.7 %id)
BU726828 eye, human retina .f 401 to 692 310 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 292/292
(100 %)
0 diff
(100 %id)
D60289   .f 406 to 690 285 to 1   fully sequenced,   285/285
(100 %)
0 diff
(100 %id)
CB070339 Pancreas, Purified pancreatic islet .f 410 to 691 282 to 1   fully sequenced,   282/282
(100 %)
0 diff
(100 %id)
FN168781 breast carcinoma .f 420 to 514 99 to 4     Submitted on the opposite strand 96/99
(96 %)
0 diff
(100 %id)
D60102   .f 420 to 692 278 to 1   fully sequenced,   278/278
(100 %)
4 diff
(98.6 %id)
N27953 melanocyte .f 420 to 692 274 to 1   fully sequenced,   274/274
(100 %)
1 diff
(99.7 %id)
DB367002   .f 423 to 692 270 to 1   fully sequenced,   270/270
(100 %)
1 diff
(99.7 %id)
FN159876 breast carcinoma .f 427 to 524 1 to 94       94/94
(100 %)
5 diff
(94.7 %id)
W46969 senescent fibroblast .f 427 to 696 277 to 1   fully sequenced,   277/277
(100 %)
6 diff
(97.9 %id)
D80281 brain .f 428 to 691 265 to 1   fully sequenced,   265/265
(100 %)
0 diff
(100 %id)
N67757 melanocyte .f 438 to 692 258 to 1   fully sequenced,   258/258
(100 %)
2 diff
(99.3 %id)
CA848242 Pancreas, Purified pancreatic islet .f 475 to 691 217 to 1   fully sequenced,   217/217
(100 %)
0 diff
(100 %id)
AA074220 pineal gland .f 520 to 684 174 to 8       167/176
(94 %)
0 diff
(100 %id)
FN162170 breast carcinoma .f 572 to 664 1 to 93       93/114
(81 %)
1 diff
(99.2 %id)
EC444809 Prostate .f 577 to 689 124 to 13       112/124
(90 %)
0 diff
(100 %id)
EC472090 Prostate .f 577 to 686 110 to 3       108/110
(98 %)
0 diff
(100 %id)
EC510168 Prostate .f 580 to 691 121 to 13   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 109/111
(98 %)
5 diff
(95.5 %id)
EC538843 Prostate .f 580 to 685 106 to 6       101/108
(93 %)
0 diff
(100 %id)
R25185 placenta .f 580 to 693 114 to 1       114/114
(100 %)
0 diff
(100 %id)
EC503524 Prostate .f 581 to 691 114 to 7       108/114
(94 %)
0 diff
(100 %id)
CB107310 Liver .f 581 to 691 1 to 111       111/116
(95 %)
1 diff
(99.2 %id)
EC531391 Prostate .f 584 to 688 110 to 7       104/112
(92 %)
0 diff
(100 %id)
FN167765 breast carcinoma .f 584 to 677 1 to 91       91/101
(90 %)
9 diff
(91.1 %id)
FN056999 breast carcinoma .f 587 to 689 1 to 103       103/107
(96 %)
1 diff
(99.1 %id)
FN154467 breast carcinoma .f 599 to 690 89 to 1     Submitted on the opposite strand 89/89
(100 %)
6 diff
(93.3 %id)
FN136834 breast carcinoma .f 600 to 657 60 to 1     Submitted on the opposite strand 60/60
(100 %)
2 diff
(96.7 %id)
BG419592 Kidney, renal cell adenocarcinoma .g 1 to 733 8 to 739 exact tiling clone,   739/740
(99 %)
9 diff
(98.8 %id)
BE268414 Burkitt lymphoma, lymph .h 1 to 632 1 to 630   available from MGC,   630/630
(100 %)
6 diff
(99.1 %id)
BG164037 hypernephroma, cell line, Kidney .h 9 to 772 1 to 767   tiling clone,   767/1097
(69 %)
23 diff
(98.0 %id)
BC007223 Lymph, Burkitt lymphoma .h 20 to 1464 1 to 1445   tiling clone, available from MGC, AAA   1445/1445
(100 %)
0 diff
(100 %id)
BE267886 Burkitt lymphoma, lymph .h 21 to 650 1 to 629       629/629
(100 %)
2 diff
(99.7 %id)
BE269372 Burkitt lymphoma, lymph .h 21 to 612 1 to 591       591/591
(100 %)
4 diff
(99.4 %id)
BE560213 Burkitt lymphoma, lymph .h 21 to 567 1 to 548       548/548
(100 %)
5 diff
(99.1 %id)
BF034408 adenocarcinoma, ovary .h 30 to 687 1 to 656       656/656
(100 %)
6 diff
(99.1 %id)
BG118043 adenocarcinoma, cell line, Liver .h 777 to 1370 1 to 593   AAA   593/593
(100 %)
2 diff
(99.7 %id)
DC392985 breast, tumor tissue .i 1 to 541 1 to 541   tiling clone,   541/541
(100 %)
0 diff
(100 %id)
AK097281 Spleen .i 331 to 2311 1 to 1981 exact tiling clone, available from FLJ,   1981/1981
(100 %)
0 diff
(100 %id)
DA949661 Spleen .i 332 to 897 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DB333711 Spleen .i 1759 to 2311 557 to 1       557/565
(98 %)
4 diff
(99.3 %id)
BG056174 brain, glioblastoma with probably TP53 mutation andwithout EGFR amplification .i 1896 to 2319 424 to 1   tiling clone,   424/424
(100 %)
0 diff
(100 %id)
R68498 placenta .j 1 to 309 1 to 314   tiling clone, to resequence,   314/374
(83 %)
15 diff
(96.0 %id)
R68499 placenta .j 1413 to 1789 382 to 1   tiling clone, to resequence,   382/437
(87 %)
5 diff
(98.9 %id)
BM791453 stomach .k 1 to 680 1 to 680 exact tiling clone,   680/680
(100 %)
0 diff
(100 %id)
BX280215 ovarian tumor, ovary .k 9 to 501 1 to 493 exact     493/493
(100 %)
0 diff
(100 %id)
AA291410 ovarian tumor, ovary .k 9 to 453 1 to 445 exact     445/445
(100 %)
0 diff
(100 %id)
BG760252 melanotic melanoma, high MDR (cell line), skin .k 11 to 751 1 to 741 exact     741/741
(100 %)
1 diff
(99.9 %id)
BG761048 melanotic melanoma, high MDR (cell line), skin .k 11 to 760 1 to 750 exact tiling clone, AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 750/750
(100 %)
1 diff
(99.9 %id)
BG766240 melanotic melanoma, high MDR (cell line), skin .k 14 to 759 1 to 752 Q8L Y9S A10V S11W L12R ...     752/813
(92 %)
9 diff
(98.9 %id)
AA294845 Pancreas .k 26 to 309 1 to 285       285/288
(98 %)
4 diff
(98.7 %id)
AW959230   .k 26 to 605 1 to 581 exact     581/587
(98 %)
9 diff
(98.5 %id)
BU163605 ductal carcinoma, cell line, Pancreas .k 43 to 757 1 to 715 exact     715/953
(75 %)
8 diff
(99.2 %id)
TI_57227761   .k 43 to 595 51 to 603 exact     553/553
(100 %)
0 diff
(100 %id)
BI520430 brain, medulla .k 44 to 747 1 to 704 exact fully sequenced, AAA   704/704
(100 %)
5 diff
(99.3 %id)
BI868702 adenocarcinoma, cell line, Liver .k 44 to 595 1 to 552 exact     552/552
(100 %)
0 diff
(100 %id)
BM923425 pooled colon, kidney, stomach .k 44 to 652 12 to 621 exact     610/1169
(52 %)
29 diff
(97.6 %id)
TI_43963809   .k 44 to 747 104 to 807 exact fully sequenced, AAA   704/807
(87 %)
11 diff
(98.7 %id)
AL550321 placenta, Placenta Cot 25-normalized .k 52 to 758 25 to 731 exact fully sequenced,   707/731
(96 %)
0 diff
(100 %id)
AW821744 stomach .k 55 to 327 1 to 273       273/273
(100 %)
1 diff
(99.7 %id)
H95884 pineal gland .k 55 to 349 1 to 305       305/305
(100 %)
16 diff
(94.8 %id)
CR624938 Placenta Cot 25-normalized .k 60 to 758 1 to 699 exact     699/699
(100 %)
0 diff
(100 %id)
BE409579 choriocarcinoma, placenta .k 60 to 758 805 to 109 N31D   Submitted on the opposite strand 697/948
(73 %)
5 diff
(99.5 %id)
BF339784 brain, glioblastoma with EGFR amplification .k 60 to 759 7 to 704 exact AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 698/704
(99 %)
13 diff
(98.2 %id)
BU553953 ovary, teratocarcinoma, cell line .k 60 to 751 43 to 734 exact AAA   692/742
(93 %)
8 diff
(99.0 %id)
C15024   .k 62 to 268 1 to 207       207/207
(100 %)
0 diff
(100 %id)
TI_149292754   .k 72 to 759 770 to 83 exact AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 688/689
(99 %)
0 diff
(100 %id)
R74300 placenta .k 77 to 395 1 to 318       318/524
(60 %)
9 diff
(98.3 %id)
BM974817 lung .k 92 to 759 686 to 19 exact AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 668/668
(100 %)
0 diff
(100 %id)
BM691258 eye, RPE and Choroid .k 92 to 760 1 to 667 exact fully sequenced, Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 667/667
(100 %)
10 diff
(98.6 %id)
N42417 melanocyte .k 94 to 414 1 to 329   fully sequenced,   329/329
(100 %)
2 diff
(99.4 %id)
BI520649 brain, medulla .k 109 to 707 599 to 1 exact fully sequenced,   599/599
(100 %)
7 diff
(98.9 %id)
BM792814 Ascites, stomach .k 137 to 544 1 to 408 exact     408/408
(100 %)
1 diff
(99.8 %id)
H23762 brain .k 138 to 512 1 to 381 R25X D26G I27H D28R Q30P ... fully sequenced,   381/381
(100 %)
5 diff
(98.7 %id)
AL550483 placenta, Placenta Cot 25-normalized .k 185 to 706 522 to 1 D2H D26X D32V fully sequenced,   522/522
(100 %)
4 diff
(99.3 %id)
TI_43963810   .k 185 to 707 524 to 1 exact fully sequenced,   524/524
(100 %)
6 diff
(98.9 %id)
BU726444 eye, RPE and Choroid .k 300 to 760 479 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 461/461
(100 %)
0 diff
(100 %id)
N33444 melanocyte .k 353 to 760 414 to 1   fully sequenced,   414/414
(100 %)
5 diff
(98.8 %id)
R74207 placenta .k 389 to 739 351 to 1       351/477
(73 %)
0 diff
(100 %id)
H95885 pineal gland .k 430 to 718 291 to 1       291/291
(100 %)
3 diff
(99.0 %id)
AA403313 ovarian tumor, ovary .k 468 to 761 295 to 2       294/295
(99 %)
0 diff
(100 %id)
H23733 brain .k 482 to 759 281 to 1   fully sequenced,   281/281
(100 %)
2 diff
(99.3 %id)
BQ639804 eye, retina .l 1 to 628 1 to 626 exact tiling clone,   626/626
(100 %)
2 diff
(99.7 %id)
CR600460 Placenta Cot 25-normalized .l 51 to 748 1 to 698 exact tiling clone,   698/698
(100 %)
0 diff
(100 %id)
AL546870 placenta, Placenta Cot 25-normalized .l 51 to 748 1 to 698 exact fully sequenced,   698/698
(100 %)
1 diff
(99.9 %id)
AL546839 placenta, Placenta Cot 25-normalized .l 172 to 681 558 to 42 D26N fully sequenced,   517/558
(92 %)
1 diff
(99.9 %id)
BM741994 stomach .m-u 1 to 551 1 to 549 F89Y tiling clone, AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 549/549
(100 %)
3 diff
(99.5 %id)
AW167312 serous papillary carcinoma, high grade, 2pooled tumors, uterus .m-u 138 to 382 246 to 1       246/246
(100 %)
3 diff
(98.8 %id)
BF725872 eye, Iris .n 1 to 550 1 to 550 exact tiling clone,   550/550
(100 %)
4 diff
(99.3 %id)
DB147532 thymus .o-u 1 to 486 2 to 487 exact tiling clone, capped   486/486
(100 %)
0 diff
(100 %id)
AA716359 heart .p 1 to 316 315 to 1 W22S L23S T24R P25L V26* tiling clone,   315/315
(100 %)
4 diff
(98.8 %id)
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m-u, .n, .o-u, .p Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI